Massive Bio

is using AI in Healthcare and Cancer Therapy issues for it's customers. We have proven products and market fit and are already closing enterprise customers.

Massive Bio's mission? Changing lives for cancer patients.

We believe every cancer patient, regardless of circumstances, deserves access to the most advanced treatment options available. We help patients find and enroll into oncology clinical trials that are right for them. Our Artificial Intelligence (AI)-driven platform connects cancer patients and their doctors to bio-pharmaceutical clinical trials.

Massive Bio serves several pharmaceutical companies and contract research organizations (CROs) providing patient recruitment, site selection and real-world data services in oncology. Founded in 2015, Massive Bio is headquartered in NYC and is privately funded.